TY - JOUR AU - Castro, C. AU - Bosetti, C. AU - Malvezzi, M. AU - Bertuccio, P. AU - Levi, F. AU - Negri, E. PY - 2014 DA - 2014// TI - Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015 JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdt486 DO - 10.1093/annonc/mdt486 ID - Castro2014 ER - TY - JOUR AU - Melhado, R. E. AU - Alderson, D. AU - Tucker, O. PY - 2010 DA - 2010// TI - The Changing Face of Esophageal Cancer JO - Cancers (Basel) VL - 2 UR - https://doi.org/10.3390/cancers2031379 DO - 10.3390/cancers2031379 ID - Melhado2010 ER - TY - JOUR AU - Tepper, J. AU - Krasna, M. J. AU - Niedzwiecki, D. AU - Hollis, D. AU - Reed, C. E. AU - Goldberg, R. PY - 2008 DA - 2008// TI - Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer : CALGB 9781 JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.12.9593 DO - 10.1200/JCO.2007.12.9593 ID - Tepper2008 ER - TY - JOUR AU - Hagen, P. AU - Hulshof, M. C. C. M. AU - Lanschot, J. J. B. AU - Steyerberg, E. W. AU - Berge Henegouwen, M. I. AU - Wijnhoven, B. P. L. PY - 2012 DA - 2012// TI - Preoperative chemoradiotherapy for esophageal or junctional cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1112088 DO - 10.1056/NEJMoa1112088 ID - Hagen2012 ER - TY - JOUR AU - Shapiro, J. AU - Lanschot, J. J. B. AU - Hulshof, M. C. C. M. AU - Hagen, P. AU - Berge Henegouwen, M. I. AU - Wijnhoven, B. P. L. PY - 2015 DA - 2015// TI - Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00040-6 DO - 10.1016/S1470-2045(15)00040-6 ID - Shapiro2015 ER - TY - JOUR AU - Bennewith, K. L. AU - Dedhar, S. PY - 2011 DA - 2011// TI - Targeting hypoxic tumour cells to overcome metastasis JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-504 DO - 10.1186/1471-2407-11-504 ID - Bennewith2011 ER - TY - JOUR AU - Pettersen, E. O. AU - Ebbesen, P. AU - Gieling, R. G. AU - Williams, K. J. AU - Dubois, L. AU - Lambin, P. PY - 2015 DA - 2015// TI - Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development : the METOXIA consortium JO - J Enzyme Inhib Med Chem VL - 30 UR - https://doi.org/10.3109/14756366.2014.966704 DO - 10.3109/14756366.2014.966704 ID - Pettersen2015 ER - TY - JOUR AU - Ebbesen, P. AU - Pettersen, E. O. AU - Gorr, T. A. AU - Jobst, G. AU - Williams, K. AU - Kieninger, J. PY - 2009 DA - 2009// TI - Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies JO - J Enzyme Inhib Med Chem VL - 24 UR - https://doi.org/10.1080/14756360902784425 DO - 10.1080/14756360902784425 ID - Ebbesen2009 ER - TY - JOUR AU - Dubois, L. J. AU - Niemans, R. AU - Kuijk, S. J. A. AU - Panth, K. M. AU - Parvathaneni, N. AU - Peeters, S. G. J. A. PY - 2015 DA - 2015// TI - New ways to image and target tumour hypoxia and its molecular responses JO - Radiother Oncol VL - 116 UR - https://doi.org/10.1016/j.radonc.2015.08.022 DO - 10.1016/j.radonc.2015.08.022 ID - Dubois2015 ER - TY - JOUR AU - Smits, K. M. AU - Melotte, V. AU - Niessen, H. E. C. AU - Dubois, L. AU - Oberije, C. AU - Troost, E. G. C. PY - 2014 DA - 2014// TI - Epigenetics in radiotherapy: Where are we heading ? JO - Radiother Oncol VL - 111 UR - https://doi.org/10.1016/j.radonc.2014.05.001 DO - 10.1016/j.radonc.2014.05.001 ID - Smits2014 ER - TY - JOUR AU - Mengesha, A. AU - Dubois, L. AU - Chiu, R. K. AU - Paesmans, K. AU - Wouters, B. G. AU - Lambin, P. AU - Theys, J. PY - 2007 DA - 2007// TI - Potential and limitations of bacterial-mediated cancer therapy JO - Front Biosci VL - 12 UR - https://doi.org/10.2741/2357 DO - 10.2741/2357 ID - Mengesha2007 ER - TY - JOUR AU - Wouters, B. G. AU - Beucken, T. AU - Magagnin, M. G. AU - Lambin, P. AU - Koumenis, C. PY - 2004 DA - 2004// TI - Targeting hypoxia tolerance in cancer JO - Drug Resist Updat VL - 7 UR - https://doi.org/10.1016/j.drup.2003.12.004 DO - 10.1016/j.drup.2003.12.004 ID - Wouters2004 ER - TY - JOUR AU - Wouters, B. G. AU - Koritzinsky, M. AU - Chiu, R. K. AU - Theys, J. AU - Buijsen, J. AU - Lambin, P. PY - 2003 DA - 2003// TI - Modulation of Cell Death in the Tumor JO - Semin Oncol VL - 13 UR - https://doi.org/10.1053/srao.2003.50004 DO - 10.1053/srao.2003.50004 ID - Wouters2003 ER - TY - JOUR AU - Wouters, B. G. AU - Weppler, S. A. AU - Koritzinsky, M. AU - Landuyt, W. AU - Nuyts, S. AU - Theys, J. PY - 2002 DA - 2002// TI - Hypoxia as a target for combined modality treatments JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(01)00361-6 DO - 10.1016/S0959-8049(01)00361-6 ID - Wouters2002 ER - TY - JOUR AU - Li, X. -. F. AU - O’Donoghue, J. A. PY - 2009 DA - 2009// TI - Hypoxia in Microscopic Tumors JO - Cancer Lett VL - 264 UR - https://doi.org/10.1016/j.canlet.2008.02.037 DO - 10.1016/j.canlet.2008.02.037 ID - Li2009 ER - TY - JOUR AU - Stiekema, J. AU - Vermeulen, D. AU - Vegt, E. AU - Voncken, F. E. M. AU - Aleman, B. M. P. AU - Sanders, J. PY - 2014 DA - 2014// TI - Detecting Interval Metastases and Response Assessment Using F-FDG PET / CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer JO - Clin Nucl Med VL - 39 UR - https://doi.org/10.1097/RLU.0000000000000517 DO - 10.1097/RLU.0000000000000517 ID - Stiekema2014 ER - TY - JOUR AU - Sun, J. D. AU - Liu, Q. AU - Wang, J. AU - Ahluwalia, D. AU - Ferraro, D. AU - Wang, Y. PY - 2012 DA - 2012// TI - Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-1980 DO - 10.1158/1078-0432.CCR-11-1980 ID - Sun2012 ER - TY - JOUR AU - Hu, J. AU - Handisides, D. R. AU - Van, V. E. AU - De, R. H. AU - Menu, E. AU - Vande, B. I. PY - 2010 DA - 2010// TI - Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-02-269126 DO - 10.1182/blood-2010-02-269126 ID - Hu2010 ER - TY - JOUR AU - Liapis, V. AU - Labrinidis, A. AU - Zinonos, I. AU - Hay, S. AU - Ponomarev, V. AU - Panagopoulos, V. PY - 2015 DA - 2015// TI - Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma JO - Cancer Lett VL - 357 UR - https://doi.org/10.1016/j.canlet.2014.11.020 DO - 10.1016/j.canlet.2014.11.020 ID - Liapis2015 ER - TY - JOUR AU - Peeters, S. G. J. A. AU - Zegers, C. M. L. AU - Biemans, R. AU - Lieuwes, N. G. AU - Stiphout, R. G. P. M. AU - Yaromina, A. PY - 2015 DA - 2015// TI - TH-302 in combination with radiotherapy enhances the therapeutic outcome and is associated with pretreatment [18 F]HX4 hypoxia PET imaging JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0018 DO - 10.1158/1078-0432.CCR-15-0018 ID - Peeters2015 ER - TY - JOUR AU - Saggar, J. K. AU - Tannock, I. F. PY - 2014 DA - 2014// TI - Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy JO - Int J Cancer VL - 134 UR - https://doi.org/10.1002/ijc.28595 DO - 10.1002/ijc.28595 ID - Saggar2014 ER - TY - JOUR AU - Liu, Q. AU - Sun, J. D. AU - Wang, J. AU - Ahluwalia, D. AU - Baker, A. F. AU - Cranmer, L. D. PY - 2012 DA - 2012// TI - TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules JO - Cancer Chemother Pharmacol VL - 69 UR - https://doi.org/10.1007/s00280-012-1852-8 DO - 10.1007/s00280-012-1852-8 ID - Liu2012 ER - TY - JOUR AU - Portwood, S. AU - Lal, D. AU - Hsu, Y. -. C. AU - Vargas, R. AU - Johnson, M. K. AU - Wetzler, M. PY - 2013 DA - 2013// TI - Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0674 DO - 10.1158/1078-0432.CCR-13-0674 ID - Portwood2013 ER - TY - JOUR AU - Ganjoo, K. N. AU - Cranmer, L. D. AU - Butrynski, J. E. AU - Rushing, D. AU - Adkins, D. AU - Okuno, S. H. PY - 2011 DA - 2011// TI - A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma JO - Oncology VL - 80 UR - https://doi.org/10.1159/000327739 DO - 10.1159/000327739 ID - Ganjoo2011 ER - TY - JOUR AU - Weiss, G. J. AU - Infante, J. R. AU - Chiorean, E. G. AU - Borad, M. J. AU - Bendell, J. C. AU - Molina, J. R. PY - 2011 DA - 2011// TI - Cancer Therapy : Clinical Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3425 DO - 10.1158/1078-0432.CCR-10-3425 ID - Weiss2011 ER - TY - JOUR AU - Chawla, S. P. AU - Cranmer, L. D. AU - Tine, B. a. AU - Reed, D. R. AU - Okuno, S. H. AU - Butrynski, J. E. PY - 2014 DA - 2014// TI - Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.3660 DO - 10.1200/JCO.2013.54.3660 ID - Chawla2014 ER - TY - JOUR AU - Borad, M. J. AU - Reddy, S. G. AU - Bahary, N. AU - Uronis, H. E. AU - Sigal, D. AU - Cohn, A. L. PY - 2015 DA - 2015// TI - Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.55.7504 DO - 10.1200/JCO.2014.55.7504 ID - Borad2015 ER - TY - JOUR AU - Zegers, C. M. L. AU - Elmpt, W. AU - Hoebers, F. J. P. AU - Troost, E. G. C. AU - Öllers, M. C. AU - Mottaghy, F. M. AU - Lambin, P. PY - 2015 DA - 2015// TI - Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma JO - Acta Oncol (Madr) VL - 54 UR - https://doi.org/10.3109/0284186X.2015.1062913 DO - 10.3109/0284186X.2015.1062913 ID - Zegers2015 ER - TY - JOUR AU - Zegers, C. M. L. AU - Elmpt, W. AU - Szardenings, K. AU - Kolb, H. AU - Waxman, A. AU - Subramaniam, R. M. PY - 2015 DA - 2015// TI - Repeatability of hypoxia PET imaging using [18 F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3100-z DO - 10.1007/s00259-015-3100-z ID - Zegers2015 ER - TY - JOUR AU - Wack, L. J. AU - Mönnich, D. AU - Elmpt, W. AU - Zegers, C. M. L. AU - Troost, E. G. C. AU - Zips, D. AU - Thorwarth, D. PY - 2015 DA - 2015// TI - HX4 for PET imaging of hypoxia – a simulation study JO - Acta Oncol (Madr) VL - 54 UR - https://doi.org/10.3109/0284186X.2015.1067721 DO - 10.3109/0284186X.2015.1067721 ID - Wack2015 ER - TY - JOUR AU - Loon, J. AU - Janssen, M. H. M. AU - Ollers, M. AU - Aerts, H. J. W. L. AU - Dubois, L. AU - Hochstenbag, M. PY - 2010 DA - 2010// TI - PET imaging of hypoxia using [18 F]HX4: a phase I trial JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-010-1437-x DO - 10.1007/s00259-010-1437-x ID - Loon2010 ER - TY - JOUR AU - Peeters, S. G. J. A. AU - Zegers, C. M. L. AU - Lieuwes, N. G. AU - Elmpt, W. AU - Eriksson, J. AU - Dongen, G. A. M. S. PY - 2015 DA - 2015// TI - A Comparative Study of the Hypoxia PET Tracers [18 F]HX4, [18 F]FAZA, and [18 F]FMISO in a Preclinical Tumor Model JO - Int J Radiat Oncol VL - 91 UR - https://doi.org/10.1016/j.ijrobp.2014.09.045 DO - 10.1016/j.ijrobp.2014.09.045 ID - Peeters2015 ER - TY - JOUR AU - Zegers, C. M. L. AU - Elmpt, W. AU - Wierts, R. AU - Reymen, B. AU - Sharifi, H. AU - Öllers, M. C. PY - 2013 DA - 2013// TI - Hypoxia imaging with [18F]HX4 PET in NSCLC patients: defining optimal imaging parameters JO - Radiother Oncol VL - 109 UR - https://doi.org/10.1016/j.radonc.2013.08.031 DO - 10.1016/j.radonc.2013.08.031 ID - Zegers2013 ER - TY - JOUR AU - Zegers, C. M. L. AU - Elmpt, W. AU - Reymen, B. AU - Even, A. J. G. AU - Troost, E. G. C. AU - Ollers, M. C. PY - 2014 DA - 2014// TI - In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18 F]HX4 and [18 F]FDG-PET/CT Imaging JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-1524 DO - 10.1158/1078-0432.CCR-14-1524 ID - Zegers2014 ER - TY - JOUR AU - Dubois, L. J. AU - Lieuwes, N. G. AU - Janssen, M. H. M. AU - Peeters, W. J. M. AU - Windhorst, A. D. PY - 2011 DA - 2011// TI - Preclinical evaluation and valication of [18 F]HX4, a promising hypoxia marker for PET imaging JO - Proc Natl Acad Sci VL - 108 UR - https://doi.org/10.1073/pnas.1102526108 DO - 10.1073/pnas.1102526108 ID - Dubois2011 ER - TY - JOUR AU - Klaassen, R. AU - Bennink, R. J. AU - Tienhoven, G. AU - Bijlsma, M. F. AU - Besselink, M. G. H. AU - Berge Henegouwen, M. I. PY - 2015 DA - 2015// TI - Feasibility and repeatability of PET with the hypoxia tracer [18 F]HX4 in oesophageal and pancreatic cancer JO - Radiother Oncol VL - 116 UR - https://doi.org/10.1016/j.radonc.2015.05.009 DO - 10.1016/j.radonc.2015.05.009 ID - Klaassen2015 ER - TY - JOUR AU - Glimelius, B. AU - Lahn, M. PY - 2011 DA - 2011// TI - Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq622 DO - 10.1093/annonc/mdq622 ID - Glimelius2011 ER - TY - STD TI - Storer BE. Design and analysis of phase I clinical trials. Biometrics. 1989;45:3. ID - ref38 ER - TY - JOUR AU - Tourneau, C. AU - Lee, J. J. AU - Siu, L. L. PY - 2009 DA - 2009// TI - Dose escalation methods in phase i cancer clinical trials JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp079 DO - 10.1093/jnci/djp079 ID - Tourneau2009 ER - TY - JOUR AU - Mandard, A. -. M. AU - Dalibard, F. AU - Mandard, J. -. C. AU - Marnay, J. AU - Henry-Amar, M. AU - Pefiot, J. PY - 1994 DA - 1994// TI - Pathologic Assessment of Tumor Regression after Preoperative Chemoradiotherapy of Esophageal Carcinoma Clinicopa thologic Correlations JO - Cancer VL - 73 UR - https://doi.org/3.0.CO;2-C DO - 3.0.CO;2-C ID - Mandard1994 ER - TY - JOUR AU - Rademakers, S. E. AU - Span, P. N. AU - Kaanders, J. H. A. M. AU - Sweep, F. C. G. J. AU - Kogel, A. J. AU - Bussink, J. PY - 2008 DA - 2008// TI - Molecular aspects of tumour hypoxia JO - Mol Oncol VL - 2 UR - https://doi.org/10.1016/j.molonc.2008.03.006 DO - 10.1016/j.molonc.2008.03.006 ID - Rademakers2008 ER - TY - JOUR AU - Clavien, P. AU - Barkun, J. AU - Oliveira, M. L. AU - Vauthey, J. N. AU - Dindo, D. AU - Schulick, R. D. PY - 2009 DA - 2009// TI - The Clavien-Dindo Classification of Surgical Complications Five-Year Experience The Clavien-Dindo Classification of Surgical Complications JO - Ann Surg VL - 250 UR - https://doi.org/10.1097/SLA.0b013e3181b13ca2 DO - 10.1097/SLA.0b013e3181b13ca2 ID - Clavien2009 ER - TY - JOUR AU - Noordman, B. J. AU - Shapiro, J. AU - Spaander, M. C. AU - Krishnadath, K. K. AU - Laarhoven, H. W. AU - Berge Henegouwen, M. I. PY - 2015 DA - 2015// TI - Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol JO - JMIR Res Protoc VL - 4 UR - https://doi.org/10.2196/resprot.4320 DO - 10.2196/resprot.4320 ID - Noordman2015 ER - TY - JOUR AU - Calais, J. AU - Dubray, B. AU - Nkhali, L. AU - Thureau, S. AU - Lemarignier, C. AU - Modzelewski, R. PY - 2015 DA - 2015// TI - High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-015-3004-y DO - 10.1007/s00259-015-3004-y ID - Calais2015 ER - TY - JOUR AU - Lambin, P. AU - Rios-Velazquez, E. AU - Leijenaar, R. AU - Carvalho, S. AU - Stiphout, R. G. P. M. AU - Granton, P. PY - 2012 DA - 2012// TI - Radiomics: extracting more information from medical images using advanced feature analysis JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.11.036 DO - 10.1016/j.ejca.2011.11.036 ID - Lambin2012 ER - TY - JOUR AU - Leijenaar, R. T. H. AU - Carvalho, S. AU - Hoebers, F. J. P. AU - Aerts, H. J. W. L. AU - Elmpt, W. J. C. AU - Huang, S. H. PY - 2015 DA - 2015// TI - External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma JO - Acta Oncol (Madr) VL - 54 UR - https://doi.org/10.3109/0284186X.2015.1061214 DO - 10.3109/0284186X.2015.1061214 ID - Leijenaar2015 ER - TY - STD TI - Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Cavalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. ID - ref47 ER - TY - JOUR AU - Carvalho, S. AU - Leijenaar, R. T. H. AU - Velazquez, E. R. AU - Oberije, C. AU - Parmar, C. AU - Elmpt, W. PY - 2013 DA - 2013// TI - Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer JO - Acta Oncol (Madr) VL - 52 UR - https://doi.org/10.3109/0284186X.2013.812795 DO - 10.3109/0284186X.2013.812795 ID - Carvalho2013 ER - TY - JOUR AU - Hatt, M. AU - Majdoub, M. AU - Vallieres, M. AU - Tixier, F. AU - Cheze Le Rest, C. AU - Groheux, D. PY - 2015 DA - 2015// TI - FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.114.144055 DO - 10.2967/jnumed.114.144055 ID - Hatt2015 ER - TY - JOUR AU - Hatt, M. AU - Visvikis, D. AU - Albarghach, N. M. AU - Tixier, F. AU - Pradier, O. AU - Cheze-le, R. C. PY - 2011 DA - 2011// TI - Prognostic value of 18 F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1755-7 DO - 10.1007/s00259-011-1755-7 ID - Hatt2011 ER - TY - JOUR AU - Yip, S. S. F. AU - Coroller, T. P. AU - Sanford, N. N. AU - Huynh, E. AU - Mamon, H. AU - Aerts, H. J. W. L. AU - Berbeco, R. I. PY - 2016 DA - 2016// TI - Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction JO - Phys Med Biol VL - 61 UR - https://doi.org/10.1088/0031-9155/61/2/906 DO - 10.1088/0031-9155/61/2/906 ID - Yip2016 ER - TY - JOUR AU - Lambin, P. AU - Zindler, J. AU - Vanneste, B. AU - Voorde, L. AU - Jacobs, M. AU - Eekers, D. PY - 2015 DA - 2015// TI - Modern clinical research : How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine JO - Acta Oncol (Madr) VL - 54 UR - https://doi.org/10.3109/0284186X.2015.1062136 DO - 10.3109/0284186X.2015.1062136 ID - Lambin2015 ER -